Pituitary apoplexy following adenoviral vector-based COVID-19 vaccination

Pituitary apoplexy (PA) may complicate the course of coronavirus disease 2019 (COVID-19), posing a potential threat to life. Among vaccines designed to prevent COVID-19, there are those adenoviral vector-based, such as Vaxzevria® (formerly COVID-19 Vaccine AstraZeneca). The product insert states tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Roncati, Luca, Manenti, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017089/
https://www.ncbi.nlm.nih.gov/pubmed/35464129
http://dx.doi.org/10.1016/j.hest.2022.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017089/
https://www.ncbi.nlm.nih.gov/pubmed/35464129
http://dx.doi.org/10.1016/j.hest.2022.04.002

Ejemplares similares